...
首页> 外文期刊>Journal of Clinical Microbiology >Analysis of Human Papillomavirus Type 16 (HPV16) DNA Load and Physical State for Identification of HPV16-Infected Women with High-Grade Lesions or Cervical Carcinoma
【24h】

Analysis of Human Papillomavirus Type 16 (HPV16) DNA Load and Physical State for Identification of HPV16-Infected Women with High-Grade Lesions or Cervical Carcinoma

机译:人类乳头瘤病毒16型(HPV16)DNA负载和身体状态分析以鉴定HPV16感染的高级别病变或宫颈癌妇女

获取原文
           

摘要

Integration of human papillomavirus (HPV) DNA into the host cell genome is a frequent event in cervical carcinogenesis, even though this phenomenon does not seem to be mandatory for cervical cancer development. Our objective was to describe the load and physical state of HPV type 16 (HPV16) DNA in a series of cervical samples representative of the natural history of cervical cancer. We used a combination of three real-time PCR assays targeting E6, E2, and albumin genes to calculate HPV16 load (E6 and albumin) and the E2/E6 ratio as a surrogate of integration. This method was applied to 173 HPV16-positive cervical samples. Results show that viral load increases with the lesion grade (from 102 HPV16 DNA copies per 103 cells in normal samples up to 56,354 copies per 103 cells in cancers), while E2/E6 ratio decreases (from 1 in normal samples down to 0.36 in cancers). We propose that, according to this technique, an HPV16 viral load of higher than 22,000 copies/103 cells or an E2/E6 ratio of lower than 0.50 allows the identification of women with prevalent high-grade lesions or worse with a high specificity. In conclusion, both viral load and E2/E6 ratio, used in combination with an appropriate cutoff value, are suitable to screen women with prevalent cervical intraepithelial neoplasia grade 2 or 3 or cancer. Therefore, these assays would be useful in addition to routine HPV testing to more accurately identify women with (pre)cancerous lesions.
机译:将人乳头瘤病毒(HPV)DNA整合到宿主细胞基因组中是宫颈癌发生中的常见事件,尽管这种现象似乎对于宫颈癌的发展并不是强制性的。我们的目的是描述代表宫颈癌自然史的一系列宫颈样本中HPV 16型(HPV16)DNA的负荷和物理状态。我们结合了针对E6,E2和白蛋白基因的三种实时PCR分析方法来计算HPV16载量(E6和白蛋白)和E2 / E6比率,作为整合的替代指标。该方法应用于173例HPV16阳性宫颈样本。结果表明,病毒载量随病灶级别的增加而增加(从正常样品中每10 3 细胞102个HPV16 DNA拷贝到癌症中每10 3 细胞56,354个拷贝)。 E2 / E6比率下降(从正常样本中的1下降到癌症中的0.36)。我们建议,根据该技术,HPV16病毒载量高于22,000拷贝/ 10 3 细胞或E2 / E6比率低于0.50可以鉴别出具有普遍高度病变的女性甚至更高的特异性。总之,病毒载量和E2 / E6比率与适当的临界值结合使用,适合筛查患有2级或3级宫颈上皮内瘤样变或癌症的女性。因此,这些检测方法除了常规的HPV检测外,还可用于更准确地鉴定患有(癌前)病变的女性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号